LILLY FDA Approval NDA 021235

NDA 021235

LILLY

FDA Drug Application

Application #021235

Documents

Letter2004-08-25
Letter2006-04-13
Letter2009-02-03
Letter2011-04-13
Letter2011-06-23
Letter2013-01-07
Letter2014-07-24
Label2006-09-21
Label2007-08-03
Label2008-03-13
Label2008-03-24
Label2009-02-04
Label2011-04-04
Label2011-04-04
Label2011-04-04
Label2011-06-16
Label2013-01-07
Label2013-01-07
Label2013-07-30
Label2014-07-23
Label2015-08-06
Review2004-10-18
Review2013-10-23
Letter2001-02-26
Letter2005-12-06
Letter2005-02-23
Letter2007-03-23
Letter2007-08-07
Letter2008-03-12
Letter2008-03-24
Letter2011-04-13
Letter2011-04-13
Letter2013-01-07
Letter2013-07-30
Letter2015-08-06
Label2001-02-26
Other Important Information from FDA2005-08-01
Label2017-01-06
Letter2017-01-13
Label2017-03-27
Medication Guide2017-03-27
Letter2017-03-29

Application Sponsors

NDA 021235LILLY

Marketing Status

Discontinued001

Application Products

001CAPSULE, DELAYED REL PELLETS;ORALEQ 90MG BASE1PROZAC WEEKLYFLUOXETINE HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2001-02-26STANDARD
LABELING; LabelingSUPPL2AP2004-08-19STANDARD
LABELING; LabelingSUPPL3AP2005-12-01STANDARD
LABELING; LabelingSUPPL4AP2005-02-18STANDARD
LABELING; LabelingSUPPL6AP2006-04-11STANDARD
LABELING; LabelingSUPPL7AP2006-09-20STANDARD
LABELING; LabelingSUPPL8AP2007-03-15STANDARD
LABELING; LabelingSUPPL9AP2007-08-02STANDARD
LABELING; LabelingSUPPL10AP2008-03-09STANDARD
LABELING; LabelingSUPPL11AP2008-03-21STANDARD
LABELING; LabelingSUPPL14AP2009-01-30901 REQUIRED
LABELING; LabelingSUPPL15AP2011-04-04STANDARD
LABELING; LabelingSUPPL16AP2011-04-04UNKNOWN
LABELING; LabelingSUPPL17AP2011-04-04UNKNOWN
LABELING; LabelingSUPPL18AP2011-06-15STANDARD
LABELING; LabelingSUPPL19AP2013-01-03STANDARD
LABELING; LabelingSUPPL20AP2013-01-03STANDARD
LABELING; LabelingSUPPL21AP2013-07-26UNKNOWN
LABELING; LabelingSUPPL23AP2017-03-24STANDARD
LABELING; LabelingSUPPL24AP2014-07-18901 REQUIRED
LABELING; LabelingSUPPL25AP2015-08-04STANDARD
LABELING; LabelingSUPPL26AP2017-01-04901 REQUIRED

Submissions Property Types

SUPPL15Null7
SUPPL16Null6
SUPPL17Null6
SUPPL18Null6
SUPPL19Null6
SUPPL20Null6
SUPPL21Null7
SUPPL23Null7
SUPPL24Null7
SUPPL25Null7
SUPPL26Null15

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21235
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.